Cargando…

Timing for Step-Down Therapy of Candidemia in Non-Neutropenic Patients: An International Multi-Center Study

BACKGROUND: Candida bloodstream infection (BSI) remains one of the leading causes of BSI in critically ill and immunosuppressed cancer patients. In light of the changing epidemiology and rising resistant species, duration of treatment and appropriate timing of stepdown therapy from intravenous (IV)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Husni, Rola, Chrabieh, Remie, Dib, Rita Wilson, Vazquez, Jose, Guimaraes, Thais, Fernández, Ana, Khoury, Rita, Asmar, Lina, Khazen, Georges, Samaha, Nadia, Raad, Issam, Hachem, Ray
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Università Cattolica del Sacro Cuore 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114892/ https://www.ncbi.nlm.nih.gov/pubmed/34007419 http://dx.doi.org/10.4084/MJHID.2021.031

Ejemplares similares

Appropriate Duration of Intravenous Treatment of Candidemia and Timing of Step Down to Oral Therapy in Non-neutropenic Patients
por: Dib, Rita Wilson, et al.
Publicado: (2018)

Perception of the Lebanese Adults about Vaccination: A Survey
por: Sakr, Rania, et al.
Publicado: (2023)

859. The Role of Procalcitonin in Antimicrobial De-escalation and Stewardship Program in Febrile Neutropenic Cancer Patients
por: Dagher, Hiba, et al.
Publicado: (2023)

1228. The Role of Procalcitonin (PCT) and Lactic Acid in Febrile Neutropenic Cancer Patients in an Oncological Emergency Center
por: Chaftari, Patrick, et al.
Publicado: (2020)

Candidemia in Febrile Neutropenic Patients; a Brief Report
por: Yousefi, Maysam, et al.
Publicado: (2018)

Itraconazole IV solution in the treatment of candidemia in non-neutropenic patients
por: Tuil, O, et al.
Publicado: (2003)

Anidulafungin for candidemia/invasive candidiasis in non-neutropenic ICU patients
por: Ruhnke, M, et al.
Publicado: (2011)

Comparing Diagnostic-Driven Approaches to Empiric Therapy in the Treatment of Invasive Aspergillosis in Patients with Hematologic Malignancy
por: Dib, Rita Wilson, et al.
Publicado: (2017)

Treating invasive aspergillosis in patients with hematologic malignancy: diagnostic-driven approach versus empiric therapies
por: Dib, Rita Wilson, et al.
Publicado: (2018)

2099. Catheter-related Staphylococcus aureus Bacteremia and Septic Thrombosis: The Role of Anticoagulation and Duration of Intravenous Antibiotic Therapy
por: Dib, Rita Wilson, et al.
Publicado: (2018)

Catheter-Related Staphylococcus aureus Bacteremia and Septic Thrombosis: The Role of Anticoagulation Therapy and Duration of Intravenous Antibiotic Therapy
por: Wilson Dib, Rita, et al.
Publicado: (2018)

A Fatal Case of Candida auris and Candida tropicalis Candidemia in Neutropenic Patient
por: Mohd Tap, Ratna, et al.
Publicado: (2018)

The clinical outcomes and predictive factors for in-hospital mortality in non-neutropenic patients with candidemia
por: Wang, Tsai-Yu, et al.
Publicado: (2016)

2453. Repeated Exposures to Minocycline/Rifampin and + Chlorhexidine Combination Used to Coat Catheters Fails to Induce Antimicrobial Resistance
por: Vargas-Cruz, Nylev, et al.
Publicado: (2018)

1488. Invasive Pulmonary Aspergillosis in Patients with Solid Tumors: Risk Factors and Predictors of Clinical Outcomes
por: Dandachi, Dima, et al.
Publicado: (2018)

Multifaceted Evaluation of Antibiotic Therapy as a Factor Associated with Candidemia in Non-Neutropenic Patients
por: Kim, Si-Ho, et al.
Publicado: (2023)

2100. Nitroglycerin-Citrate-Ethanol Catheter Lock Solution Is Highly Effective in Eradicating Candida auris Biofilms
por: Rosenblatt, Joel, et al.
Publicado: (2018)

272. Invasive Pulmonary Aspergillosis: Comparative Analysis in cancer patients with Underlying Hematologic Malignancy vs. Solid Tumor
por: Wilson Dib, Rita, et al.
Publicado: (2019)

Prevalence of candidemia and associated candida subtypes following severe sepsis in non-neutropenic critically ill patients
por: Kashiha, Arefeh, et al.
Publicado: (2018)

1182. The Real-World Use of Isavuconazole as Primary or salvage Therapy of Invasive Fungal infections in High-Risk Patients with Hematologic Malignancy or Stem Cell Transplant
por: dagher, Hiba, et al.
Publicado: (2020)

414. Diagnostic Usefulness of Differential Time to Positivity (DTP) in Neutropenic Cancer Patients With Suspected Catheter-Related Candidemia (CRC)
por: Jo, Kyeong Min, et al.
Publicado: (2018)

1036. Whole Genome Sequencing Analysis of a Large Cohort of Staphylococcus epidermidis Blood Culture Positive Isolates From a Multicenter Clinical Trial
por: Dib, Rita Wilson, et al.
Publicado: (2018)

Spontaneous complete resolution of alopecia totalis post SARS-CoV-2 infection
por: Chidiac, Georgio, et al.
Publicado: (2022)

Real-World Use of Isavuconazole as Primary Therapy for Invasive Fungal Infections in High-Risk Patients with Hematologic Malignancy or Stem Cell Transplant
por: Dagher, Hiba, et al.
Publicado: (2022)

1257. A phase II Prospective Randomized Study to Assess Ceftolozane-Tazobactam in the Management of Febrile Neutropenia in Patients with Hematological Malignancies
por: Chaftari, Anne-Marie, et al.
Publicado: (2020)

Insights on the Role of Antimicrobial Cuffed Endotracheal Tubes in Preventing Transtracheal Transmission of VAP Pathogens from an In Vitro Model of Microaspiration and Microbial Proliferation
por: Rosenblatt, Joel, et al.
Publicado: (2014)

810. Resistance to the Minocycline-Rifampin-Chlorhexidine (MRCH) combination does not emerge in biofilms of Tetracycline and Rifampin resistant bacteria grown on MRCH catheters depleted below antimicrobially effective concentrations
por: Gerges, Bahgat, et al.
Publicado: (2020)

Top-down characterization data on the speciation of the Candida albicans immunome in candidemia
por: Pitarch, Aida, et al.
Publicado: (2015)

Management of enterococcal central line-associated bloodstream infections in patients with cancer
por: Awadh, Hesham, et al.
Publicado: (2021)

120. The Impact of Early Central Venous Catheter Removal in the Management of Enterococcus Central Line-Associated Bloodstream Infections
por: Awadh, Hesham, et al.
Publicado: (2019)

1636. Risk of Latent Tuberculosis Reactivation in Patients Treated with Checkpoint Inhibitors Immunotherapy Compared to Other Anti-Cancer Therapies including Hematopoietic Cell Transplantation
por: Malek, Alexandre, et al.
Publicado: (2020)

363. A Phase II Prospective Randomized Study to Assess Imipenem-Relebactam in the Management of Cancer Patients with Febrile Neutropenia
por: Chaftari, Anne-Marie, et al.
Publicado: (2023)

Neutropenic Fever
por: Baluch, Aliyah, et al.
Publicado: (2019)

683. Assessment of Biofilm Eradication and Cytotoxicity of a Novel Polygalacturonic Acid + Caprylic Acid Wound Ointment Compared with Antiseptic Wound Ointments
por: Gerges, Bahgat, et al.
Publicado: (2019)

Severe acute respiratory syndrome coronavirus 2 antibody seroprevalence in Lebanon: a population-based cross-sectional study
por: Mahdi, Ahmad, et al.
Publicado: (2022)

The use of minocycline-rifampin coated central venous catheters for exchange of catheters in the setting of staphylococcus aureus central line associated bloodstream infections
por: Chaftari, Anne-Marie, et al.
Publicado: (2014)

Caprylic and Polygalacturonic Acid Combinations for Eradication of Microbial Organisms Embedded in Biofilm
por: Rosenblatt, Joel, et al.
Publicado: (2017)

Foley Catheter with Peri-Urethral Antimicrobial Irrigation for the Prevention of Catheter Associated Urinary Tract Infections – Assessment in an In Vitro Model
por: Rosenblatt, Joel, et al.
Publicado: (2017)

1709 Mycobacterium Arupense in Cancer Patients: A Commensal Organism or a Pathogen?
por: Jordan, Mary, et al.
Publicado: (2014)

Pilot Ex Vivo and In Vitro Evaluation of a Novel Foley Catheter with Antimicrobial Periurethral Irrigation for Prevention of Extraluminal Biofilm Colonization Leading to Catheter-Associated Urinary Tract Infections (CAUTIs)
por: Vargas-Cruz, Nylev, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4n5bf5iogq0ve1nh77g4sh4tr8